Eric Dobmeier - Nov 10, 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Nov 10, 2023
Transactions value $
$101,340
Form type
4
Date filed
11/14/2023, 06:27 PM
Previous filing
Aug 11, 2023
Next filing
Jun 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Purchase $101K +447K +383.54% $0.23* 563K Nov 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.